Survey and Research Archives | Page 130 of 142 | Be Korea-savvy

Archive by category Survey and Research

Following Four Years of FMCG Slowdown and Explosive Digital Growth in China, Shopper Attitude and Loyalty Towards Brands is Mostly Unchanged

Following Four Years of FMCG Slowdown and Explosive Digital Growth in China, Shopper Attitude and Loyalty Towards Brands is Mostly Unchanged

BEIJING, Oct. 24 (Korea Bizwire) — Following four years of significant growth in China, e-commerce continues to steadily gain acceptance among consumers, bringing about some clear and noticeable changes to shopping and consumption habits.  However, according to volume two of Bain & Company and Kantar Worldpanel’s 2017 China shopper report, Keeping up with China’s Shoppers [...]

Corporate R&D Spending Hits Record Highs for the Top 1000, Despite Concerns of Economic Protectionism

Corporate R&D Spending Hits Record Highs for the Top 1000, Despite Concerns of Economic Protectionism

NEW YORK, Oct. 24 (Korea Bizwire) — Annual worldwide corporate R&D spending broke through $700bn in annual investment, according to an annual analysis of R&D spending across 1000 global public companies by PwC’s Strategy&. It shows corporate R&D spending increased a steady 3% in the past year, bouncing back from less than 1% increase previously. [...]

Rapid Micro Biosystems Awarded a Contract by Biomedical Advanced Research and Development Authority (BARDA) for the Implementation of a Rapid Sterility Test for Vaccines

Rapid Micro Biosystems Awarded a Contract by Biomedical Advanced Research and Development Authority (BARDA) for the Implementation of a Rapid Sterility Test for Vaccines

LOWELL, Mass., Oct. 23 (Korea Bizwire) — Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, is pleased to announce the receipt of a $7.3 million contract from the Biomedical Advanced Research and Development Authority (BARDA) for the implementation of a rapid sterility test for vaccines. This awarded grant is part of [...]

Payvision’s Annual Report Reveals Cross-border Ecommerce Trends in 2017

Payvision’s Annual Report Reveals Cross-border Ecommerce Trends in 2017

AMSTERDAM, The Netherlands, Oct. 19 (Korea Bizwire) — Payvision, global acquirer and data-driven omnichannel solutions provider, has published the findings of its fifth annual cross-border ecommerce research report, in collaboration with Juniper Research. The paper includes the results of a global survey of various industry players regarding the game-changers, the biggest challenges, the best practices [...]

World Conference on Lung Cancer Wednesday Press Conference: PD-1/PD-L1 Advancements and Interventions to Prevent and Treat Lung Cancer

World Conference on Lung Cancer Wednesday Press Conference: PD-1/PD-L1 Advancements and Interventions to Prevent and Treat Lung Cancer

YOKOHAMA, Japan, Oct. 18 (Korea Bizwire) — The final press conference from the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) highlighted new advancements surrounding the discovery of PD-1 and PD-L1, including a discussion from the researcher credited with discovering PD-1, as well as interventions to prevent lung [...]

World Conference on Lung Cancer Tuesday Press Conference: Evidence to Support Innovative Lung Cancer Interventions

World Conference on Lung Cancer Tuesday Press Conference: Evidence to Support Innovative Lung Cancer Interventions

YOKOHAMA, Japan, Oct. 17 (Korea Bizwire) — Today’s press conference at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) featured groundbreaking findings in the study of both small cell and non-small cell lung cancer. The studies presented covered broad research areas, from confirmation of existing classification [...]

World Conference on Lung Cancer Monday Press Conference: Dangers of Smoking and Lung Cancer Intervention Research

World Conference on Lung Cancer Monday Press Conference: Dangers of Smoking and Lung Cancer Intervention Research

YOKOHAMA, Japan, Oct. 16 (Korea Bizwire) — At today’s press conference at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC), the world’s preeminent lung cancer researchers provided new insights on CT screening, smoking cessation and mesothelioma. The discussion focused in particular on the conference’s host country of [...]

World Conference on Lung Cancer Sunday Press Conference: Introducing New Awards and Global Guidelines

World Conference on Lung Cancer Sunday Press Conference: Introducing New Awards and Global Guidelines

YOKOHAMA, Japan, Oct. 15 (Korea Bizwire) — The first press briefing at the International Association for the Study of Lung Cancer (IASLC) 18th World Conference on Lung Cancer (WCLC) highlighted new awards and innovations that encourage and support the treatment of lung cancer and other thoracic malignancies; these include the recognition of outstanding care teams, [...]

First Quantitative M&A Brand Study of S&P Global 100 Shows 74 percent Rebrand Post-acquisition; Sector, Deal Size, and Appetite Key Factors

First Quantitative M&A Brand Study of S&P Global 100 Shows 74 percent Rebrand Post-acquisition; Sector, Deal Size, and Appetite Key Factors

NEW YORK, Oct. 10 (Korea Bizwire) — In 2015 and 2016, mergers and acquisitions accounted for more than $8 trillion of business value. But while extensive due diligence and planning is given to financials and other factors during the deal-making process, brand strategy considerations are often overlooked or only evaluated post-M&A. This is due, in [...]

RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

TEL-AVIV, Israel and RALEIGH, N.C., Oct. 3 (Korea Bizwire) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary, orally-administered, small molecule drugs for gastrointestinal and inflammatory diseases and cancer, today announced positive top-line results from the Phase II [...]